Background In patients with type 2 diabetes, sodium-glucose cotransporter-2 (SGLT2)
inhibitors are known to reduce glucose concentrations, blood pressure, and weight, but to …

Diabetic nephropathy has been traditionally diagnosed based on persistently high
albuminuria and a subsequent decline in glomerular filtration rate (GFR), which is widely …

Introduction The burden of chronic kidney disease (CKD) is growing rapidly around the
world. However, there is limited information on the overall regional prevalence of CKD, as …

Background: Hyperkalemia increases risk of cardiac arrhythmias and death and limits the
use of renin-angiotensin-aldosterone system inhibitors and mineralocorticoid receptor …

Aim The use of sodium glucose co‐transporter 2 (SGLT2) inhibitors in patients with type 2
diabetes mellitus (T2DM) and chronic kidney disease (CKD) has been limited, primarily …

We investigated the biodegradation of pyrene and benzo [a] pyrene in Phragmites australis
rhizosphere sediment. We collected P. australis plants, rhizosphere sediments, and …

OBJECTIVE We evaluated the structural-functional relationships and the prognostic factors
for renal events, cardiovascular events, and all-cause mortality in type 2 diabetic patients …

Tissue kallikreins are a group of serine proteases that are found in many organs and
biologic fluids. Tissue kallikrein genes (KLKs) are found on chromosome 19q13. 3–4 as a …

Background: Effects of oral anticoagulation in chronic kidney disease (CKD) are uncertain.
Purpose: To evaluate the benefits and harms of vitamin K antagonists (VKAs) and non …

Background The number of patients suffering from diabetic nephropathy resulting in end-
stage kidney disease is increasing worldwide. In clinical settings, there are limited data …